Cervical Cancer Screening Data from the Case-based National Electronic Registry in Bangladesh

preprint OA: closed
Full text JSON View at publisher
AI-generated summary by claude@2026-07, 2026-07-17

This study analyzed cervical cancer screening data from Bangladesh's electronic registry, revealing that out of 1.56 million women screened, 3.3% were VIA-positive, with low follow-up rates for colposcopy and treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Abstract Introduction: The purpose of this study is to review the cervical cancer surveillance situation of Bangladeshi women based on the data of the national cervical cancer screening, treatment, and follow-up programme which uses longitudinal data tracking through a DHIS2-based electronic registry. Methods: Women aged 30 to 60 were enrolled in the DHIS2 electronic registry in health facilities of all tiers and screened for cervical cancer using the VIA method. The VIA-positive women had their colposcopy in the nearest colposcopy centres. The VIA- and colposcopy-positive women were treated and followed up at certain intervals following the national standard protocol. During each encounter, required data were captured in DHIS2. Data from the DHIS2 covering January 2018 to May 2023 were extracted and analysed for this study. Results: In 6,895 health facilities, 1,562,963 women were enrolled. Among them, 1,557,002 (99.6%) availed VIA tests at 1,094 centres. Primary healthcare facilities performed 74.4% enrolments and 72% VIA tests. 51,913 (3.3%) women were VIA-positive, of which only 20,954 (40.4%) attended for colposcopy. Among the colposcopy-positive women, 6.3% (1,327) and 6.2% (1,302) women had CIN II/III and cervical carcinoma respectively; 81.6% (5,062) of the cervical pre-cancerous women received thermal ablation and 17.6% (1089) received Loop Electrosurgical Excision Procedure (LEEP). Distribution of histopathology reports (n = 3,079) revealed 16.1% (n = 495) squamous cell carcinoma, 4.0% (n = 123) micro-invasive squamous cell carcinoma, 11.7% (n = 36) CIN II and 8.1% (n = 250) CIN III. Conclusions: The sustainable national cervical cancer screening and treatment programme for women in Bangladesh using an effective DHIS2-based electronic case-based tracking system can be a valuable lesson for other countries.
Full text 15,229 characters · extracted from preprint-html · click to expand
Cervical Cancer Screening Data from the Case-based National Electronic Registry in Bangladesh | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Cervical Cancer Screening Data from the Case-based National Electronic Registry in Bangladesh Ashrafun Nessa, Abul Kalam Azad, Shekh Md. Nizam Uddin, Muhammad Abdul Hannan Khan, and 2 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-4672043/v1 This work is licensed under a CC BY 4.0 License Status: Under Review Version 1 posted 12 You are reading this latest preprint version Abstract Introduction: The purpose of this study is to review the cervical cancer surveillance situation of Bangladeshi women based on the data of the national cervical cancer screening, treatment, and follow-up programme which uses longitudinal data tracking through a DHIS2-based electronic registry. Methods: Women aged 30 to 60 were enrolled in the DHIS2 electronic registry in health facilities of all tiers and screened for cervical cancer using the VIA method. The VIA-positive women had their colposcopy in the nearest colposcopy centres. The VIA- and colposcopy-positive women were treated and followed up at certain intervals following the national standard protocol. During each encounter, required data were captured in DHIS2. Data from the DHIS2 covering January 2018 to May 2023 were extracted and analysed for this study. Results : In 6,895 health facilities, 1,562,963 women were enrolled. Among them, 1,557,002 (99.6%) availed VIA tests at 1,094 centres. Primary healthcare facilities performed 74.4% enrolments and 72% VIA tests. 51,913 (3.3%) women were VIA-positive, of which only 20,954 (40.4%) attended for colposcopy. Among the colposcopy-positive women, 6.3% (1,327) and 6.2% (1,302) women had CIN II/III and cervical carcinoma respectively; 81.6% (5,062) of the cervical pre-cancerous women received thermal ablation and 17.6% (1089) received Loop Electrosurgical Excision Procedure (LEEP). Distribution of histopathology reports (n = 3,079) revealed 16.1% (n = 495) squamous cell carcinoma, 4.0% (n = 123) micro-invasive squamous cell carcinoma, 11.7% (n = 36) CIN II and 8.1% (n = 250) CIN III. Conclusions : The sustainable national cervical cancer screening and treatment programme for women in Bangladesh using an effective DHIS2-based electronic case-based tracking system can be a valuable lesson for other countries. Cervical cancer Cervical cancer screening VIA DHIS2 Bangladesh Electronic data tracking NCBCSP Digital health Full Text Additional Declarations No competing interests reported. Cite Share Download PDF Status: Under Review Version 1 posted Editorial decision: Revision requested 20 Sep, 2024 Reviews received at journal 19 Sep, 2024 Reviews received at journal 18 Sep, 2024 Reviewers agreed at journal 10 Sep, 2024 Reviewers agreed at journal 09 Sep, 2024 Reviews received at journal 11 Aug, 2024 Reviewers agreed at journal 06 Aug, 2024 Reviewers invited by journal 17 Jul, 2024 Editor invited by journal 08 Jul, 2024 Editor assigned by journal 02 Jul, 2024 Submission checks completed at journal 02 Jul, 2024 First submitted to journal 02 Jul, 2024 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-4672043","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":330111869,"identity":"b5d82f92-949a-43d3-ac1b-1d9f498443a5","order_by":0,"name":"Ashrafun Nessa","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA30lEQVRIiWNgGAWjYFACHiC2YWDgl4AJHGBgAwvi15LGwCA5g2QtBjeI1cLff/bYhx8Jh/OMb7c/3XSzjUGO70YC24M3eLRI3MhLntmTcLjY7M4Zs9u5bQzGkjcS2A3n4HPXDR5jBt4fhxO33chhA2lJ3AC0RRqfw+TPnzFm/JNwOHHzjPRnIC31BLUYHMgxZuYBatkgkQB2WIIBIS2GN4BaZBLSE2eA/JJzTsJw5pmH7Xj9Igdy2JsE68T+2e3PbueU2cjzHU8+hjfE0AEoDTA2kKBhFIyCUTAKRgE2AABa9FMX5Ka2ggAAAABJRU5ErkJggg==","orcid":"","institution":"Bangabandhu Sheikh Mujib Medical University","correspondingAuthor":true,"submittingAuthor":false,"prefix":"","firstName":"Ashrafun","middleName":"","lastName":"Nessa","suffix":""},{"id":330111871,"identity":"baeb34d3-bfb8-4c2a-9d0a-841d39f6e607","order_by":1,"name":"Abul Kalam Azad","email":"","orcid":"","institution":"Directorate General of Health Services, Bangladesh (formerly as Director General)","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Abul","middleName":"Kalam","lastName":"Azad","suffix":""},{"id":330111872,"identity":"dd245406-0c33-47cc-9d19-c95936c7f760","order_by":2,"name":"Shekh Md. Nizam Uddin","email":"","orcid":"","institution":"Health Information System Program, Bangladesh","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Shekh","middleName":"Md. Nizam","lastName":"U","suffix":"Md."},{"id":330111873,"identity":"022fab8c-af23-401b-a855-232921ce6e6d","order_by":3,"name":"Muhammad Abdul Hannan Khan","email":"","orcid":"","institution":"Health Information System Program, Bangladesh","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Muhammad","middleName":"Abdul Hannan","lastName":"Khan","suffix":""},{"id":330111874,"identity":"861e7569-4122-4f07-8de0-91adb9561ee8","order_by":4,"name":"Shreshtha Zaman","email":"","orcid":"","institution":"National Center for Cervical and Breast Cancer Screening and Training, BSMMU","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Shreshtha","middleName":"","lastName":"Zaman","suffix":""},{"id":330111875,"identity":"7a81d0cd-385c-4a8e-92bf-5545e6bdb1dc","order_by":5,"name":"Abdus Salam Khan","email":"","orcid":"","institution":"Ministry of Health and Family Welfare","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Abdus","middleName":"Salam","lastName":"Khan","suffix":""}],"badges":[],"createdAt":"2024-07-02 06:55:45","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-4672043/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-4672043/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":60997744,"identity":"70e2ebad-29cb-4397-ab86-0a58f5f02e8d","added_by":"auto","created_at":"2024-07-24 12:26:09","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":349795,"visible":true,"origin":"","legend":"","description":"","filename":"ManuscriptBMCforsubmission2.7.24.pdf","url":"https://assets-eu.researchsquare.com/files/rs-4672043/v1_covered_c7de920c-1146-4937-88c9-3fef69dadae5.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"Cervical Cancer Screening Data from the Case-based National Electronic Registry in Bangladesh","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"bmc-global-and-public-health","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"Learn more about [BMC Global and Public Health](https://bmcglobalpublichealth.biomedcentral.com/)","snPcode":"44263","submissionUrl":"https://submission.springernature.com/new-submission/44263/3","title":"BMC Global and Public Health","twitterHandle":"@BMC_GPH","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"BMC Series","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"Cervical cancer, Cervical cancer screening, VIA, DHIS2, Bangladesh, Electronic data tracking, NCBCSP, Digital health","lastPublishedDoi":"10.21203/rs.3.rs-4672043/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-4672043/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eIntroduction:\u003c/p\u003e \u003cp\u003eThe purpose of this study is to review the cervical cancer surveillance situation of Bangladeshi women based on the data of the national cervical cancer screening, treatment, and follow-up programme which uses longitudinal data tracking through a DHIS2-based electronic registry.\u003c/p\u003e \u003cp\u003eMethods:\u003c/p\u003e \u003cp\u003eWomen aged 30 to 60 were enrolled in the DHIS2 electronic registry in health facilities of all tiers and screened for cervical cancer using the VIA method. The VIA-positive women had their colposcopy in the nearest colposcopy centres. The VIA- and colposcopy-positive women were treated and followed up at certain intervals following the national standard protocol. During each encounter, required data were captured in DHIS2. Data from the DHIS2 covering January 2018 to May 2023 were extracted and analysed for this study.\u003c/p\u003e \u003cp\u003e \u003cb\u003eResults\u003c/b\u003e: In 6,895 health facilities, 1,562,963 women were enrolled. Among them, 1,557,002 (99.6%) availed VIA tests at 1,094 centres. Primary healthcare facilities performed 74.4% enrolments and 72% VIA tests. 51,913 (3.3%) women were VIA-positive, of which only 20,954 (40.4%) attended for colposcopy. Among the colposcopy-positive women, 6.3% (1,327) and 6.2% (1,302) women had CIN II/III and cervical carcinoma respectively; 81.6% (5,062) of the cervical pre-cancerous women received thermal ablation and 17.6% (1089) received Loop Electrosurgical Excision Procedure (LEEP). Distribution of histopathology reports (n\u0026thinsp;=\u0026thinsp;3,079) revealed 16.1% (n\u0026thinsp;=\u0026thinsp;495) squamous cell carcinoma, 4.0% (n\u0026thinsp;=\u0026thinsp;123) micro-invasive squamous cell carcinoma, 11.7% (n\u0026thinsp;=\u0026thinsp;36) CIN II and 8.1% (n\u0026thinsp;=\u0026thinsp;250) CIN III.\u003c/p\u003e \u003cp\u003e \u003cb\u003eConclusions\u003c/b\u003e: The sustainable national cervical cancer screening and treatment programme for women in Bangladesh using an effective DHIS2-based electronic case-based tracking system can be a valuable lesson for other countries.\u003c/p\u003e","manuscriptTitle":"Cervical Cancer Screening Data from the Case-based National Electronic Registry in Bangladesh","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-07-24 12:18:02","doi":"10.21203/rs.3.rs-4672043/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2024-09-20T15:22:13+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-09-19T15:55:19+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-09-18T12:40:31+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"153544282333531882669737178912249131202","date":"2024-09-10T20:06:27+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"228653628463435920879492756018047964268","date":"2024-09-09T10:56:59+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-08-12T01:24:46+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"82731672687112994969609133170112531880","date":"2024-08-06T12:29:56+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2024-07-17T10:37:52+00:00","index":"","fulltext":""},{"type":"editorInvited","content":"","date":"2024-07-08T17:38:20+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2024-07-02T11:53:40+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2024-07-02T09:43:08+00:00","index":"","fulltext":""},{"type":"submitted","content":"BMC Global and Public Health","date":"2024-07-02T06:54:26+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"bmc-global-and-public-health","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"Learn more about [BMC Global and Public Health](https://bmcglobalpublichealth.biomedcentral.com/)","snPcode":"44263","submissionUrl":"https://submission.springernature.com/new-submission/44263/3","title":"BMC Global and Public Health","twitterHandle":"@BMC_GPH","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"BMC Series","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"169c4183-3b33-4487-81c4-279c23ba37cb","owner":[],"postedDate":"July 24th, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"under-review","subjectAreas":[],"tags":[],"updatedAt":"2025-03-10T19:22:33+00:00","versionOfRecord":[],"versionCreatedAt":"2024-07-24 12:18:02","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-4672043","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-4672043","identity":"rs-4672043","version":["v1"]},"buildId":"FbvkV6FR0MCFSLy54lSbu","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00